The effectiveness and safety of administering antiplatelet medications following reperfusion therapy in patients with ischemic stroke
TAT may enhance neurological recovery but increases bleeding risk. Patient selection and monitoring are crucial, and long-term studies are needed to fully evaluate its risk-benefit profile.
Authors
- Ningfen Wang
- Xie Ju
- Guoqing Wang (ORCID: https://orcid.org/0000-0002-1711-3656)
- Yubin Wu
Institutions
- Binzhou Medical University (CN)
- Binzhou People's Hospital (CN)
Publication Details
- Journal
- Expert Opinion on Pharmacotherapy
- Published
- 2025-06-16
- DOI
- https://doi.org/10.1080/14656566.2025.2521371
- Primary Topic
- Antiplatelet Therapy and Cardiovascular Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00